SUBSCRIPTION AGREEMENTSubscription Agreement • May 12th, 2016 • Fennec Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • British Columbia
Contract Type FiledMay 12th, 2016 Company Industry JurisdictionThis SUBSCRIPTION AGREEMENT (this “Agreement”) is made as of the latest date set forth on the signature page hereof between Fennec Pharmaceuticals Inc. (the “Company”) and the undersigned (the “Subscriber”).
Purchase AgreementPurchase Agreement • May 12th, 2016 • Fennec Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • Maryland
Contract Type FiledMay 12th, 2016 Company Industry JurisdictionThis Purchase Agreement (this "Agreement") is made as of May 9, 2016, and sets forth terms by Elion Oncology, LLC (the "Purchaser") 4800 Hampden Lane, Suite 200, Bethesda, MD 20814 will acquire from Fennec Pharmaceuticals Inc., 68 TW Alexander Dr., Triangle, NC 27709, (the "Company") all intellectual property and related property of the Company pertaining to Eniluracil and the compound known as Adh-1.